Move to 'de-risk' supply chains is leading some biotech firms to consider using Indian drug manufacturers to produce active pharmaceutical ingredient for clinical trials or other work
The spike in infections poses fresh risks for the Chinese economy which is still struggling to emerge from the economic hit from two-years of of Covid-related lockdowns and restrictions
Borrowing costs for critical the end-of-month loans for non-banks remain high despite fresh cash injections by the central bank to calm the market
Indian refiners have trouble paying for oil because Moscow prefers yuan, while Delhi likes to settle deals in UAE dirham, but that now involves extra clearing requirements
Beijing exchange's benchmark 50 Index has risen 46% this month on the back of moves by officials, including claims that major shareholders are not being permitted to sell stock
Buffett's exit comes after a string of selldowns for Paytm, including stake cuts by Japanese conglomerate SoftBank Group and the exit of China's Alibaba Group
Spot lithium prices in the world's top producer of the battery metal were effectively down close to 80% year-on-year
The crisis at Zhongzhi threatens to reignite concerns that China's property debt crisis is spilling over into the country’s broader financial sector
A wealthy Indonesian family that owns palm oil giant First Resources has been accused of secretly owning 3 firms that have allegedly cleared more rainforest than any other group in SE Asia
The Montenegrin justice minister will decide whether Kwon will go to South Korea or the US — where he faces eight charges, including securities and wire fraud
News of the delay follows analysts concerns around Nvidia’s plan to introduce three new chips for China, as developing new chips can be highly resource-intensive
A mass market EV known as the 'Model 2' is tipped to be one of the first Teslas that will go on sale in coming years; meanwhile the carmaker won a court base in China over a supposed brake failure